[Federal Register Volume 70, Number 143 (Wednesday, July 27, 2005)]
[Notices]
[Pages 43454-43455]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-14831]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated February 17, 2005, and published in the Federal 
Register on February 28, 2005, (70 FR 9677), Boehringer Ingelheim 
Chemical Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of Tetrahydrocannabinols (7370), a 
basic class of controlled substance listed in Schedule I.
    The company plans to manufacture the listed controlled substance in 
bulk for use in analysis and drug test standards.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Boehringer Ingelheim Chemical Inc. to

[[Page 43455]]

manufacture the listed basic class of controlled substance is 
consistent with the public interest at this time. DEA has investigated 
Boehringer Ingelheim Chemical Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the 
above named company is granted registration as a bulk manufacturer of 
the basic classes of controlled substances listed.

    Dated: July 19, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-14831 Filed 7-26-05; 8:45 am]
BILLING CODE 4410-09-P